FDA Says New MS Therapy Risky
Federal health regulators are once again warning patients and doctors that an experimental treatment for multiple sclerosis (MS) may be linked to life-threatening injuries including stroke and paralysis. Reuters reports that despite the warning some doctors continue to treat chronic cerebrospinal venous insufficiency (CCSVI) in MS patients with an experimental